BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3979002)

  • 1. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.
    Gugler R; Jensen JC
    Gastroenterology; 1985 Dec; 89(6):1235-41. PubMed ID: 3932118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
    Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
    Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of metronidazole on phenazone metabolism].
    Staiger C; Wang NS; de Vries J; Weber E
    Arzneimittelforschung; 1984; 34(1):89-91. PubMed ID: 6538427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.
    Neuvonen PJ; Tokola RA; Kaste M
    Eur J Clin Pharmacol; 1981; 21(3):215-20. PubMed ID: 7318881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam.
    Abernethy DR; Greenblatt DJ; Eshelman FN; Shader RI
    Clin Pharmacol Ther; 1984 Feb; 35(2):188-92. PubMed ID: 6319067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antipyrine and rifampin on the metabolism of diazepam.
    Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
    Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed clearance of diazepam due to cimetidine.
    Klotz U; Reimann I
    N Engl J Med; 1980 May; 302(18):1012-4. PubMed ID: 6767973
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and induction of metronidazole and antipyrine metabolism.
    Loft S; Sonne J; Poulsen HE; Petersen KT; Jørgensen BG; Døssing M
    Eur J Clin Pharmacol; 1987; 32(1):35-41. PubMed ID: 3582467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of antipyrine clearance in humans by propranolol.
    Greenblatt DJ; Franke K; Huffman DH
    Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
    Eichelbaum M; Ochs HR; Roberts G; Somogyi A
    Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin intoxication during concurrent diazepam therapy.
    Rogers HJ; Haslam RA; Longstreth J; Lietman PS
    J Neurol Neurosurg Psychiatry; 1977 Sep; 40(9):890-5. PubMed ID: 599366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.